Moderna says its Covid vaccine is safe and effective in children

Henrietta Brewer
May 25, 2021

Moderna did not immediately respond to a request for comment. Many states have complained about shortage of vaccines and companies have refused to give directly to state governments.

An Indian state looking to procure Covid-19 shots to combat a nationwide surge in infections today said that USA vaccine maker Moderna had declined to supply its shots and said it can only deal with the federal government.

In a press release on Tuesday, the company said its clinical trial in the U.S. showed that the shot produce an immune response against COVID-19 in adolescents similar to the response seen in adults.

Sisodia alleged the GOI allowed the two major vaccine manufacturers in the country to fix illogical differential pricing for the Central government and the state governments. Earlier this month, the U.S. Food and Drug Administration expanded clearance of the Pfizer Inc. The study met its primary goal of showing that immune responses to the vaccine in 12 to 17 year-olds were as good as those produced in adults, and no significant safety concerns were observed, according to the company.


There were no COVID-19 diagnoses in recipients given two doses of the Moderna vaccine compared with four cases among those given dummy shots.

Moderna added that its study looking at COVID-19 vaccines among children ages six months to 11 years, known as KidCOVE, is ongoing.

In addition, the vaccine was found to be 93% effective starting 14 days after the first dose for milder disease, as defined by the Centers for Disease Control and Prevention.

Meanwhile, Pfizer's two-dose jab was approved for use in those aged 15 and older in December before the age limit was dropped to 12 in May.


Depending on when the FDA application is made and how quickly it is processed, it could offer families more choices for vaccinating children over the summer vacation and before the 2021-22 school year begins.

It could also help boost vaccination rates with more than 25 million adolescents between ages 12 and 17 in the US, according to data from the Census Bureau.

He said the Central government controls the production and supply of vaccines by Indian manufacturers and it also controls the supply of vaccines by manufacturers from overseas.

Only about three in 10 parents - 29 percent - of children under 18 said they would get their child vaccinated 'right away'.


While children are far less likely than adults to get seriously ill from COVID-19, they represent about 14 per cent of the coronavirus cases in the U.S. At least 316 have died in the U.S. alone, according to a tally by the American Academy of Pediatrics.

Other reports by iNewsToday

FOLLOW OUR NEWSPAPER